Cadian Capital Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-550,000
| Closed | -$71M | – | 31 |
|
|
2019
Q4 | $71M | Sell |
550,000
-702,500
| -56% | -$90.7M | 3.14% | 14 |
|
|
2019
Q3 | $94.3M | Buy |
1,252,500
+704,000
| +128% | +$53M | 4.48% | 11 |
|
|
2019
Q2 | $83.3M | Sell |
548,500
-62,046
| -10% | -$9.43M | 3.76% | 11 |
|
|
2019
Q1 | $72.8M | Buy |
610,546
+329,000
| +117% | +$39.2M | 2.84% | 15 |
|
|
2018
Q4 | $30.7M | Sell |
281,546
-106,054
| -27% | -$11.6M | 1.43% | 21 |
|
|
2018
Q3 | $62.6M | Buy |
387,600
+107,600
| +38% | +$17.4M | 2.84% | 14 |
|
|
2018
Q2 | $37M | Buy |
+280,000
| New | +$37M | 1.78% | 19 |
|
|
2017
Q3 | – | Sell |
-621,458
| Closed | -$20.9M | – | 47 |
|
|
2017
Q2 | $20.9M | Buy |
621,458
+275,647
| +80% | +$9.29M | 1.02% | 29 |
|
|
2017
Q1 | $10.2M | Sell |
345,811
-3,143
| -0.9% | -$93K | 0.49% | 35 |
|
|
2016
Q4 | $9.57M | Buy |
+348,954
| New | +$9.57M | 0.51% | 34 |
|